Surprisingly, we also found that some immune-associated pathways upregulated in low-risk score groups in HNSCC, such as response to interleukin 4 and B cell receptor signaling pathway, implying our ERS-associated signature might be associated with immune surveillance against cancer cells. The gene discussed is IL4; the disease is cancer.